Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00378742 · ClinicalTrials.gov registry record
Repository for Inherited Eye Diseases
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 6,618
- Enrollment target
NCT00378742: Completed study, sponsored by National Eye Institute (NEI).
NCT00378742 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 6,618 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00378742 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 6,618 participants
- Enrollment target
Study Summary
The National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE(R)) is a genomic medicine initiative created by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), in partnership with clinics and laboratories across the vision research community. The core mission of eyeGENE(R) is to facilitate research into the causes and mechanisms of rare inherited eye diseases and accelerate pathways to treatments. This study collects DNA samples from patients with inherited eye diseases to facilitate research to identify genetic factors responsible for these conditions. Nearly 500 genes that contribute to inherited eye diseases have been identified. As a result, gene-based therapies are being pursued to treat eye genetic diseases that were once considered untreatable. Physicians in collaborating institutions will recruit patients to participate in the study. Patients will provide a blood sample and undergo a standard eye examination. The blood sample and clinical information will then be sent to the NEI for testing, processing and storing in the biorepository. Patients are given the option to receive results back and/or to be re-contacted in the event of future clinical studies. Information supplied to the testing laboratories includes a unique identification number, the patient gender, and the patient date of birth. The stored samples are available to researchers along with information about the patient's disease, but without patient identifiers.
Primary Outcome
Obtain and create a national DNA and blood repository for inherited eye diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,618 participants |
| Start Date | 2006-09-20 |
| Est. Completion | 2015-11-19 |
What the finished NCT00378742 record still lists
NCT00378742 is an observational study that tracks outcomes without assigning an intervention. Its 6,618 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00378742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00378742 about?
NCT00378742 is a clinical study titled "Repository for Inherited Eye Diseases". The National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE(R)) is a genomic medicine initiative created by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), in partnership with clinics and laboratories across the vision research community. The core m...
What is the current status of trial NCT00378742?
This trial is currently completed. The enrollment target is 6,618 participants. The study started on 2006-09-20. Estimated completion is 2015-11-19.
Who is sponsoring clinical trial NCT00378742?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
- NCT05515224 · 6,600 participants · NA
5-Cog 2.0: A Pragmatic Clinical Trial
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI